SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950116-99-000249
Filing Date
1999-02-16
Accepted
1999-02-16 00:00:00
Documents
1
Group Members
HAROLD R. WERNERHEALTHCARE PARTNERS II, L.P.HEALTHCARE PARTNERS III, L.P.HEALTHCARE PARTNERS IV, L.P.HEALTHCARE VENTURES II LPHEALTHCARE VENTURES II, L.P.HEALTHCARE VENTURES III, L.P.HEALTHCARE VENTURES IV, L.P.JAMES H. CAVANAUGH, PH.D.JOHN W. LITTLECHILD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A SC 13G/A 50384
  Complete submission text file 0000950116-99-000249.txt   52974
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02194-2725 6174330771
AVANT IMMUNOTHERAPEUTICS INC (Subject) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-37761 | Film No.: 99541518
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address TWIN TOWERS AT METRO PARK 379 THORNALL AVENUE EDISON NJ 08837
Business Address TWIN TOWERS AT METRO PARK 379 THORNALL AVENUE EDISON NJ 08837 9089064613
HEALTHCARE VENTURES II LP (Filed by) CIK: 0000859649 (see all company filings)

IRS No.: 223015728 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 0000